Marine Medical Solutions, a key provider of healthcare services tailored for the maritime industry, urges seafarers and ship operators to be aware of numerous infectious diseases that are in circulation, including an increase in malaria among seafarers operating in West African regions as well as a ship that has been quarantined in Argentina because of Mpox.

Dr. Jens Tülsner, CEO at Marine Medical Solutions, noted that while the overall incidence of malaria has not increased, MMS has reported a significant rise in cases that could have been easily prevented with proper medical precautions.

He said: “We are seeing more and more seafarers contracting malaria simply because they are not taking the recommended preventive medications or strict conservative preventative measures such as long-sleeve clothing, mosquito spray, and actions that make it more difficult to be bitten by the disease-carrying Anopheles mosquito. The reluctance often stems from the side effects associated with these medicines, leading many to take the risk, hoping they won’t contract malaria. Unfortunately, this gamble often results in serious illness.”

Dr. Tülsner emphasised the need for vessels to be equipped with rapid diagnostic tests (RDTs) for malaria. “By having RDTs readily available onboard, we can identify potential cases much earlier, allowing for prompt treatment before the seafarers become seriously ill. This proactive approach not only protects the health of the crew but also minimizes disruptions to vessel operations.”

With Mpox only reported on one vessel, it does not yet appear to be an issue for seafarers although seafarers and shipping companies must remain vigilant. Sloth fever, another virus in the news recently, does not yet appear to be an issue for seafarers as up until now it has been dependent on a species of mosquito only in Middle and South America. “In consequence, it underlines something that applies in general to seafarers: Get protected for insect bites,” adds Dr. Tülsner.

Marine Medical Solutions urges all shipping companies and vessel operators to ensure their crews are fully informed about the risks of malaria and other diseases in circulation and the importance of preventative measures. MMS is committed to working with its partners in the OneCare Group (OCG) to enhance the availability of testing and treatment options on vessels, ensuring the safety and well-being of all seafarers.